<SEC-DOCUMENT>0001193125-26-202381-index.html : 20260504
<SEC-HEADER>0001193125-26-202381.hdr.sgml : 20260504
<ACCEPTANCE-DATETIME>20260504060130
ACCESSION NUMBER:		0001193125-26-202381
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260429
FILED AS OF DATE:		20260504
DATE AS OF CHANGE:		20260504

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Golden Adam H.
		CENTRAL INDEX KEY:			0002130116
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-43251
		FILM NUMBER:		26934475

	MAIL ADDRESS:	
		STREET 1:		C/O AVALYN PHARMA INC.
		STREET 2:		105 W FIRST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02127

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Avalyn Pharma Inc.
		CENTRAL INDEX KEY:			0001540171
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				452463191
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		105 W FIRST ST.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02127
		BUSINESS PHONE:		(206) 707-0340

	MAIL ADDRESS:	
		STREET 1:		105 W FIRST ST.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genoa Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20120120
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>